Product Name :
Human VEGF R3 Protein
Description:
| Human VEGF R3/FLT4 Protein with the C-hFc Tag |Source: The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The recombinant Human VEGF R3/FLT4 Protein is shipped with ice |Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 week, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Source:
The recombinant Human VEGF R3/FLT4 Protein, (amino acids Tyr25-Ile776) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight :
The recombinant Human VEGF R3/FLT4 protein with the hFc tag at the C-terminus has a predicted MW of 111.3 kDa. Due to glycosylation, the protein migrates to 135-155 kDa based on Bis-Tris PAGE result.
Activity:
Immobilized recombinant Human VEGF-C protein with the C-hFc tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human VEGF R3 protein with the C-hFc tag with the EC50 of 17.9 ng/ml determined by ELISA.
Purity :
>95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin:
LevelLess than 1 EU per ug of protein as determined by LAL method.
Formulation :
Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution:
It is recommended to reconstitute the lyophilized recombinant Human VEGF R3/FLT4 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening. BP005029Human VEGF R3/FLT4 Protein with the C-His-Avi Tag SourceThe recombinant Human VEGF R3/FLT4 Protein, (amino acids Tyr25-Ile776) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Shipping:
The recombinant Human VEGF R3/FLT4 Protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage :
/strong>Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
GRP-78 Proteincustom synthesis
EphA4 ProteinSource
Popular categories:
IFN-lambda 1/IL-29
SMAD7